Local Treatment of Burns with Cell-Based Therapies Tested in Clinical Studies

Abstract

Effective wound management is an important determinant of the survival and prognosis of patients with severe burns. Thus, novel techniques for timely and full closure of full-thickness burn wounds are urgently needed. The purpose of this review is to present the current state of knowledge on the local treatment of burn wounds (distinguishing radiation injury from other types of burns) with the application of cellular therapies conducted in clinical studies. PubMed search engine and ClinicalTrials.gov were used to analyze the available data. The analysis covered 49 articles, assessing the use of keratinocytes (30), keratinocytes and fibroblasts (6), fibroblasts (2), bone marrow-derived cells (8), and adipose tissue cells (3). Studies on the cell-based products that are commercially available (Epicel®, Keraheal™, ReCell®, JACE, Biobrane®) were also included, with the majority of reports found on autologous and allogeneic keratinocytes. Promising data demonstrate the effectiveness of various cell-based therapies; however, there are still scientific and technical issues that need to be solved before cell therapies become standard of care. Further evidence is required to demonstrate the clinical efficacy and safety of cell-based therapies in burns. In particular, comparative studies with long-term follow-up are critical.

Clinical Indications of Cultured Epithelial Autografts

“…An institution that does not have access to a laboratory can choose to outsource to third-party biotechnology companies. While these companies take care of growing and maintaining the culture, the logistics of shipping and transporting the culture further inflate the cost 74 …”

The Role of Skin Substitutes in Acute Burn and Reconstructive Burn Surgery: An Updated Comprehensive Review

“…8 Epicel ( Genzyme Biosurgery, Cambridge, MA ) is the most known form of CEA and has been widely used in the burn community. 58 It is cultured from full-thickness biopsies from the patient's skin and usually applied in combination with STSG or alone in severe burns involving an extensive amount of the TBSA. Studies have pointed out its limitations including the high costs, fragility, and long preparation time.…”

Sprayable Bioactive Dressings for Skin Wounds: Recent Developments and Future Prospects

“…For these cases, the use of allogeneic epidermal cells is an alternative. Several studies using cultured fibroblasts or allogeneic keratinocytes show their potential use with satisfactory results for both acute [124,125] and hard-to-heal [126][127][128] wounds. The main advantage would be the immediate treatment of the patient [124], with fewer complications and a greater chance of cure.…”